In a report released yesterday, Anne Samuel from J.P. Morgan maintained a Hold rating on Convey Holding Parent (CNVY – Research Report), with a price target of $10.50. The company’s shares closed last Tuesday at $10.30.
According to TipRanks.com, Samuel is a 4-star analyst with an average return of 16.5% and a 44.4% success rate. Samuel covers the Technology sector, focusing on stocks such as Definitive Healthcare Corp, Health Catalyst, and Signify Health.
Currently, the analyst consensus on Convey Holding Parent is a Hold with an average price target of $9.83, which is a -4.6% downside from current levels. In a report released yesterday, Canaccord Genuity also downgraded the stock to Hold.
Based on Convey Holding Parent’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $96.71 million and GAAP net loss of $1.15 million. In comparison, last year the company earned revenue of $82.63 million and had a GAAP net loss of $934K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Convey Holding Parent Inc is a healthcare platform that utilizes technology and processes to improve government-sponsored health plans, including Medicare Advantage. It operates in two segments: Technology-Enabled Solutions, in which it provides technology and support solutions to clients, and Advisory Services, in which it provides project-based consulting services through its long-tenured subject matter experts.
Read More on CNVY:
- Digihost Completes Acquisition of 55 MW Site in Alabama
- OneWater Marine Inc. Signs Definitive Agreement to Acquire Ocean Bio-Chem, Inc.
- Winnebago Industries Delivers Record Third Quarter Fiscal 2022 Results
- Medicenna Reports Fiscal Year 2022 Financial Results and Operational Highlights
- Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend